REGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: REGN Shares Outstanding History and REGN YTD Return |
REGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: REGN Shares Outstanding History and REGN YTD Return |
REGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+30.01% CAGR Mouse over chart for data details
|
REGN Stock Price Chart |
About Regeneron Pharmaceuticals, Inc. |
Regeneron Pharmaceuticals is a biotechnology company. Co.'s products include: EYLEA, which is designed for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema, myopic choroidal neovascularization, diabetic retinopathy, neovascular glaucoma and retinopathy of prematurity; Dupixent, which is designed for the treatment of atopic dermatitis, asthma, rhinosinusitis with nasal polyposis, eosinophilic esophagitis (in adults and adolescents) and prurigo nodularis; and Libtayo, which is designed for the treatment of metastatic or locally advanced first-line non-small cell lung cancer and metastatic or recurrent second-line cervical cancer. We show 56 historical shares outstanding datapoints in our REGN shares outstanding history coverage, used to compute REGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing REGN market cap history over the course of time is important for investors interested in comparing REGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of REGN versus a peer is one thing; comparing REGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like REGN can fluctuate over the course of history. With this page we aim to empower investors researching REGN by allowing them to research the REGN market cap history. |
REGN Current Stock Quote |
Free REGN Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
REGN Share Performance |
Market Cap Peers |
Regeneron Pharmaceuticals (REGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
RENB Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.